Vijaya Diagnostic Centre Limited Market Cap ($1.61 Billion)
Market Cap & Net Worth: Vijaya Diagnostic Centre Limited (VIJAYA)
Vijaya Diagnostic Centre Limited market cap. Vijaya Diagnostic Centre Limited (NSE:VIJAYA) has a market capitalization of $1.61 Billion (Rs149.05 Billion) as of November 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #6684 globally and #311 in its home market, demonstrating a 3.68% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vijaya Diagnostic Centre Limited's stock price Rs1447.10 by its total outstanding shares 102997715 (103.00 Million). Also see cash efficiency ratio of Vijaya Diagnostic Centre Limited for how efficiently the company converts equity into cash flow.
Vijaya Diagnostic Centre Limited Market Cap History (2021–2026)
Vijaya Diagnostic Centre Limited market cap history from 2021 to 2026. Data shows growth from $645.13 Million to $1.61 Billion (18.06% CAGR). Check VIJAYA live share price for real-time trading data and today's change.
Index Memberships
Vijaya Diagnostic Centre Limited is a constituent of 4 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY 500
NIFTY500
|
$3.02 Trillion | 0.05% | #269 of 500 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$1.09 Trillion | 0.15% | #181 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.10 Trillion | 0.05% | #267 of 750 |
|
NIFTY SMALLCAP 250
NISM250
|
$388.02 Billion | 0.42% | #86 of 250 |
Weight: Vijaya Diagnostic Centre Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Vijaya Diagnostic Centre Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vijaya Diagnostic Centre Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore VIJAYA year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.20x
Vijaya Diagnostic Centre Limited's market cap is 0.20 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.93x
Vijaya Diagnostic Centre Limited's market cap is 0.93 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $645.13 Million | $3.76 Billion | $844.78 Million | 0.17x | 0.76x |
| 2022 | $485.36 Million | $4.62 Billion | $1.10 Billion | 0.11x | 0.44x |
| 2023 | $751.81 Million | $4.59 Billion | $846.32 Million | 0.16x | 0.89x |
| 2024 | $1.18 Billion | $5.48 Billion | $1.19 Billion | 0.21x | 0.99x |
| 2025 | $1.18 Billion | $6.81 Billion | $1.43 Billion | 0.17x | 0.83x |
| 2026 | $1.61 Billion | $8.14 Billion | $1.73 Billion | 0.20x | 0.93x |
Competitor Companies of VIJAYA by Market Capitalization
Companies near Vijaya Diagnostic Centre Limited in the global market cap rankings as of November 4, 2026. Also see Vijaya Diagnostic Centre Limited total assets for a full breakdown of the balance sheet.
Key companies related to Vijaya Diagnostic Centre Limited by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #142 globally with a market cap of $162.54 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #479 globally with a market cap of $56.02 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #546 globally with a market cap of $48.96 Billion USD ( CN¥334.59 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $698.34 |
| #142 | Danaher Corporation | NYSE:DHR | $162.54 Billion | $230.11 |
| #479 | Natera Inc | NASDAQ:NTRA | $56.02 Billion | $388.63 |
| #546 | WuXi AppTec Co Ltd | SHG:603259 | $48.96 Billion | CN¥135.28 |
Market Capitalization of Vijaya Diagnostic Centre Limited (2021–2026)
Market capitalization of Vijaya Diagnostic Centre Limited from 2021 to today. Between 2021 and today, Vijaya Diagnostic Centre Limited's market cap moved from $645.13 Million to $ 1.61 Billion, with a yearly change of 18.06%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs1.61 Billion | +36.39% |
| 2025 | Rs1.18 Billion | +0.39% |
| 2024 | Rs1.18 Billion | +56.58% |
| 2023 | Rs751.81 Million | +54.90% |
| 2022 | Rs485.36 Million | -24.76% |
| 2021 | Rs645.13 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Vijaya Diagnostic Centre Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.61 Billion USD |
| MoneyControl | $1.61 Billion USD |
| MarketWatch | $1.61 Billion USD |
| marketcap.company | $1.61 Billion USD |
| Reuters | $1.61 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Vijaya Diagnostic Centre Limited
Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T ser… Read more